Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Clinical trial NCT03166735 · COMPLETED

Trial details

NCT number: NCT03166735
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2017-06-06
Primary completion: 2019-06-14
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.